Heme oxygenase and nitric oxide synthase in human middle ear epithelium indicates local carbon monoxide and nitric oxide production

Acta Oto-Laryngologica

Volumn 122, Issue 6, 2002, Pages 634-637

  Andersson, J A ^a   Uddman, R ^a   Tajti, J ^b   Cardell, L O ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Carbon monoxide; Immunocytochemistry; Nitric oxide

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; ENZYME REGULATION; EPITHELIUM; GAS ANALYSIS; GAS EXCHANGE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MIDDLE EAR; MIDDLE EAR DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARBON MONOXIDE; EAR, MIDDLE; EPITHELIUM; FEMALE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0036395205     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/000164802320396312     Document Type: Article

References (27)

1. Felding JU. Middle ear gas - its composition in the normal and in the tubulated ear. A methodological and clinical study. Acta Otolaryngol Suppl (Stockh) 1998; 536: 1-57.
2. Hergils L, Magnuson B. Human middle ear gas composition studied by mass spectrometry. Acta Otolaryngol (Stockh) 1990; 110: 92-9.
3. Ingelstedt S, Ivarsson A, Tjernstrom O. Vertigo due to relative overpressure in the middle ear. An experimental study in man. Acta Otolaryngol (Stockh) 1974; 78: 1-14.
4. Bylander-Groth A, Stenström C. Eustachian tube function and otitis media in children. Ear Nose Throat J 1998; 77: 762-764, 766, 768-769.
5. Paredi P, Kharitonov SA, Leak D, et al. Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. Am J Respir Crit Care Med 2000; 161: 1247-51.
6. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995; 1: 370-3.
7. Andersson JA, Uddman R, Cardell LO. Carbon monoxide is endogenously produced in the human nose and paranasal sinuses. J Allergy Clin Immunol 2000; 105: 269-73.
8. Olopade CO, Zakkar M, Swedler WI, Rubinstein I. Exhaled pentane levels in acute asthma. Chest 1997; 111: 862-5.
9. Zayasu K, Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H. Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1997; 156: 1140-3.
10. Conboy PJ, Jones NS. The nose and nitric oxide: a review. Clin Otolaryngol 2000; 25: 337-41.
11. Rodgers PA, Vreman HJ, Dennery PA, Stevenson DK. Sources of carbon monoxide (CO) in biological systems and applications of CO detection technologies. Semin Perinatol 1994; 18: 2-10.
12. Prabhakar NR. Endogenous carbon monoxide in control of respiration. Respir Physiol 1998; 114: 57-64.
13. Yamaya M, Sekizawa K, Ishizuka S, Monma M, Mizuta K, Sasaki H. Increased carbon monoxide in exhaled air of subjects with upper respiratory tract infections. Am J Respir Crit Care Med 1998; 158: 311-4.
14. Monma M, Yamaya M, Sekizawa K, et al. Increased carbon monoxide in exhaled air of patients with seasonal allergic rhinitis. Clin Exp Allergy 1999; 29: 1537-41.
15. Cardell LO, Lou YP, Takeyama K, Ueki IF, Lausier J, Nadel JA. Carbon monoxide, a cyclic GMP-related messenger, involved in hypoxic bronchodilation in vivo. Pulm Pharmacol Ther 1998; 11: 309-15.
16. Andersson JA, Uddman R, Cardell LO. Increased carbon monoxide levels in the nasal airways of subjects with a history of seasonal allergic rhinitis and in patients with upper respiratory tract infection. Clin Exp Allergy 2002; 32: 224-7.
17. Kawamoto H, Takumida M, Takeno S, Watanabe H, Fukushima N, Yajin K. Localization of nitric oxide synthase in human nasal mucosa with nasal allergy. Acta Otolaryngol Suppl (Stockh) 1998; 539: 65-70.
18. Riederer A, Held B, Mayer B, Worl J. Histochemical and immunocytochemical study of nitrergic innervation in human nasal mucosa. Ann Otol Rhinol Laryngol 1999; 108: 869-75.
19. Forséni M, Bagger-Sjöbäck D, Hultcrantz M. A study of inflammatory mediators in the human tympanosclerotic middle ear. Arch Otolaryngol Head Neck Surg 2001; 127: 559-64.
20. Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol 1983; 46: 198-202.
21. Croen KD. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest 1993; 91: 2446-52.
22. Lindberg S, Cervin A, Runer T. Low levels of nasal nitric oxide (NO) correlate to impaired mucociliary function in the upper airways. Acta Otolaryngol (Stockh) 1997; 117: 728-34.
23. Hebda PA, Alper CM, Doyle WJ, Burckart GJ, Diven WF, Zeevi A. Upregulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media. Ann Otol Rhinol Laryngol 1998; 107: 501-7.
24. Forséni M, Hansson GK, Bagger-Sjöbäck D, Hultcrantz M. An immunohistochemical study of inducible nitric oxide synthase in the rat middle ear, with reference to tympanosclerosis. Acta Otolaryngol (Stockh) 1999; 119: 577-82.
25. Sade J, Luntz M. Gas diffusion in the middle ear. Acta Otolaryngol (Stockh) 1991; 111: 354-7.
26. VanUffelen BE, de Koster BM, VanSteveninck J, Elferink JG. Carbon monoxide enhances human neutrophil migration in a cyclic GMP-dependent way. Biochem Biophys Res Commun 1996; 226: 21-6.
27. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 1997; 100: 1209-16.